What is RNA's dilution risk score?

RNA has a latest available DilutionScore record of 41/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RNA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RNA?

DilutionWatch tracks 25 SEC filing types for RNA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RNA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RNA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RNA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RNA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RNA Dilution Risk Score: 41/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

10

📊 Float Risk

85

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for RNA.

🔔 Track RNA — Get forecast alerts →

Market Data

Market Cap$222.37M

Shares Outstanding155.15M

Float15.76M

Cash$644.37M

Debt$2.68M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 83.5% shares (2026Q1 vs prior)

20 institutional holders · 24.56M shares

#1 Avoro Capital Advisors LLC 5.46M shares

#2 GOLDMAN SACHS GROUP INC 3.78M shares

#3 OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3.72M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.51M

Days to Cover28.4

% of Float22.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RNA Dilution Snapshot

Atrium Therapeutics, Inc. (RNA) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for RNA: xbrl on 2021-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.